Glucotrack provides shareholder update

Rutherford, nj, march 14, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today that paul v. goode, phd, president and chief executive officer has provided a shareholder update letter.

GCTK Ratings Summary

GCTK Quant Ranking